ALS Limited to Acquire Nuvisa Pharma Holding Call Transcript
Good day and thank you for standing by. Welcome to ALS Limited briefing conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today CEO, Malcolm Deane. Please go ahead.
Thank you very much, and good morning, everyone, and thank you for joining today's briefing.
The purpose of this call is to discuss our announcement this morning that ALS is taking full ownership and control of Nuvisan. And I'm joined on this call by our new Chief Financial Officer, Stuart Hutton.
Last year in November we announced that a full strategic review of our investment in Nuvisan what's necessary given the given the financial performance to date, it was important that the company undertook this review to ensure that it made the best decision on behalf of our shareholders.
Following the strategic review, ALS is pleased to announce that, today we have agreed with Nuvisan Pharma Holding GmbH to acquire the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |